First Time Loading...

Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 36 GBX -1.37%
Updated: Jun 3, 2024

Creo Medical Group PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Creo Medical Group PLC
Total Equity Peer Comparison

Comparables:
SN
LIVN
LMDX
EKF
AGL

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Total Equity
£59.8m
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Total Equity
$5.2B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Total Equity
$1.2B
CAGR 3-Years
5%
CAGR 5-Years
-4%
CAGR 10-Years
17%
LumiraDx Ltd
NASDAQ:LMDX
Total Equity
-$105.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Total Equity
£67.1m
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
5%
Angle PLC
LSE:AGL
Total Equity
£32.1m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Total Equity?
Total Equity
59.8m GBP

Based on the financial report for Dec 31, 2023, Creo Medical Group PLC's Total Equity amounts to 59.8m GBP.

What is Creo Medical Group PLC's Total Equity growth rate?
Total Equity CAGR 5Y
5%

Over the last year, the Total Equity growth was 21%. The average annual Total Equity growth rates for Creo Medical Group PLC have been -2% over the past three years , 5% over the past five years .